In a patient who exhibited markedly increased s‐MDK levels after four cycles of chemotherapy, the tumor progressed immediately after chemotherapy, although no increase in the expression of pro‐gastrin‐releasing peptide, a representative SCLC marker, was observed (Figure S1A). The gene discussed is MDK; the disease is small cell lung carcinoma.